These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 22094224

  • 1. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
    Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, Lin YF, Shih CM.
    Free Radic Biol Med; 2012 Jan 15; 52(2):377-91. PubMed ID: 22094224
    [Abstract] [Full Text] [Related]

  • 2. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G.
    Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.
    Xie L, Song X, Guo W, Wang X, Wei L, Li Y, Lv L, Wang W, Chen TC, Song X.
    Oncotarget; 2016 Jan 12; 7(2):1651-62. PubMed ID: 26625208
    [Abstract] [Full Text] [Related]

  • 4. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y, Li H, Yi D, Bai Y, Zhong S, Liu Q, Chen Y, Zhao G.
    Cancer Lett; 2018 Oct 28; 435():66-79. PubMed ID: 30081068
    [Abstract] [Full Text] [Related]

  • 5. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition.
    Liu T, Li A, Xu Y, Xin Y.
    Oncol Rep; 2019 Mar 28; 41(3):1883-1892. PubMed ID: 30664175
    [Abstract] [Full Text] [Related]

  • 6. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
    Kim SM, Woo JS, Jeong CH, Ryu CH, Jang JD, Jeun SS.
    Stem Cells Transl Med; 2014 Feb 28; 3(2):172-82. PubMed ID: 24436439
    [Abstract] [Full Text] [Related]

  • 7. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
    Golden EB, Cho HY, Jahanian A, Hofman FM, Louie SG, Schönthal AH, Chen TC.
    Neurosurg Focus; 2014 Dec 28; 37(6):E12. PubMed ID: 25434381
    [Abstract] [Full Text] [Related]

  • 8. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death.
    Cheng Y, Sk UH, Zhang Y, Ren X, Zhang L, Huber-Keener KJ, Sun YW, Liao J, Amin S, Sharma AK, Yang JM.
    PLoS One; 2012 Dec 28; 7(4):e35104. PubMed ID: 22496897
    [Abstract] [Full Text] [Related]

  • 9. A combined preclinical therapy of cannabinoids and temozolomide against glioma.
    Torres S, Lorente M, Rodríguez-Fornés F, Hernández-Tiedra S, Salazar M, García-Taboada E, Barcia J, Guzmán M, Velasco G.
    Mol Cancer Ther; 2011 Jan 28; 10(1):90-103. PubMed ID: 21220494
    [Abstract] [Full Text] [Related]

  • 10. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition.
    Zhang P, Sun S, Li N, Ho ASW, Kiang KMY, Zhang X, Cheng YS, Poon MW, Lee D, Pu JKS, Leung GKK.
    J Neurooncol; 2017 May 28; 132(3):393-400. PubMed ID: 28293765
    [Abstract] [Full Text] [Related]

  • 11. Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells.
    Hori YS, Hosoda R, Akiyama Y, Sebori R, Wanibuchi M, Mikami T, Sugino T, Suzuki K, Maruyama M, Tsukamoto M, Mikuni N, Horio Y, Kuno A.
    J Neurooncol; 2015 Mar 28; 122(1):11-20. PubMed ID: 25528635
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
    Anai S, Hide T, Takezaki T, Kuroda J, Shinojima N, Makino K, Nakamura H, Yano S, Kuratsu J.
    Cancer Sci; 2014 May 28; 105(5):583-91. PubMed ID: 24673719
    [Abstract] [Full Text] [Related]

  • 13. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
    Zhuang D, Liu Y, Mao Y, Gao L, Zhang H, Luan S, Huang F, Li Q.
    Int J Cancer; 2012 Jan 15; 130(2):309-18. PubMed ID: 21328340
    [Abstract] [Full Text] [Related]

  • 14. Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway.
    Yuan Y, Xue X, Guo RB, Sun XL, Hu G.
    CNS Neurosci Ther; 2012 Jul 15; 18(7):536-46. PubMed ID: 22530672
    [Abstract] [Full Text] [Related]

  • 15. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
    Chen PH, Cheng CH, Shih CM, Ho KH, Lin CW, Lee CC, Liu AJ, Chang CK, Chen KC.
    PLoS One; 2016 Jul 15; 11(11):e0167096. PubMed ID: 27893811
    [Abstract] [Full Text] [Related]

  • 16. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
    Dong J, Zhou G, Tang D, Chen Y, Cui B, Dai X, Zhang J, Lan Q, Huang Q.
    J Cancer Res Clin Oncol; 2012 Dec 15; 138(12):2079-84. PubMed ID: 22825126
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma.
    Liu XY, Zhang L, Wu J, Zhou L, Ren YJ, Yang WQ, Ming ZJ, Chen B, Wang J, Zhang Y, Yang JM.
    PLoS One; 2013 Dec 15; 8(11):e81345. PubMed ID: 24303044
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Jiang C, Shen F, Du J, Fang X, Li X, Su J, Wang X, Huang X, Liu Z.
    Biomed Pharmacother; 2018 Jan 15; 97():844-850. PubMed ID: 29136760
    [Abstract] [Full Text] [Related]

  • 19. Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.
    Gong A, Ge N, Yao W, Lu L, Liang H.
    Cancer Chemother Pharmacol; 2014 Sep 15; 74(3):531-8. PubMed ID: 25047724
    [Abstract] [Full Text] [Related]

  • 20. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways.
    Wu Y, Dong L, Bao S, Wang M, Yun Y, Zhu R.
    Biomed Pharmacother; 2016 Dec 15; 84():462-469. PubMed ID: 27685789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.